Back to today’s briefing

Story perspectives

China's Biotech Boom: 1,250 New Drugs in Development

7/14/2025

33 6

Summary

Story summary

China's biotechnology sector is undergoing a remarkable transformation, boasting over 1,250 innovative drugs in the pipeline, rivaling the U.S. landscape. With therapies that surpass global standards and bolstered by regulatory reforms and a vast patient base, China is emerging as a formidable force in pharmaceutical innovation, even as geopolitical tensions rise.

1 of 1

Story summary

China's biotechnology sector is undergoing a remarkable transformation, boasting over 1,250 innovative drugs in the pipeline, rivaling the U.S. landscape. With therapies that surpass global standards and bolstered by regulatory reforms and a vast patient base, China is emerging as a formidable force in pharmaceutical innovation, even as geopolitical tensions rise.